Human herpesvirus 8 K14 protein mimics CD200 in down-regulating macrophage activation through CD200 receptor

被引:90
作者
Foster-Cuevas, M [1 ]
Wright, GJ [1 ]
Puklavec, MJ [1 ]
Brown, MH [1 ]
Barclay, AN [1 ]
机构
[1] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England
关键词
D O I
10.1128/JVI.78.14.7667-7676.2004
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Many viral proteins limit host immune defenses, and their genes often originate from their hosts. CD200 (OX2) is a broadly distributed cell surface glycoprotein that interacts with a receptor on myeloid cells (CD200R) that is implicated in locally preventing macrophage activation. Distant, but recognizable, homologues of CD200 have been identified in many herpesviruses and poxviruses. Here, we show that the product of the K14 open reading frame from human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) interacts with human CD20OR and is expressed at the surfaces of infected cells solely during the lytic cycle. Despite sharing only 40% primary sequence identity, K14 and CD200 interacted with CD200R with an almost identical and low affinity (K-D = 0.5 muM), in contrast to other characterized viral homologue interactions. Cells expressing CD200 or K14 on the cell surface were able to inhibit secretion by activated macrophages of proinflammatory cytokines such as tumor necrosis factor alpha, an effect that could be specifically relieved by addition of monoclonal antibodies and soluble monomeric CD200 protein. We conclude that CD200 delivers local down-modulatory signals to myeloid cells through direct cell-cell contact and that the K14 viral homologue closely mimics this.
引用
收藏
页码:7667 / 7676
页数:10
相关论文
共 44 条
[31]   The leukocyte/neuron cell surface antigen OX2 binds to a ligand on macrophages [J].
Preston, S ;
Wright, GJ ;
Starr, K ;
Barclay, AN ;
Brown, MH .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1997, 27 (08) :1911-1918
[32]   SMART: a web-based tool for the study of genetically mobile domains [J].
Schultz, J ;
Copley, RR ;
Doerks, T ;
Ponting, CP ;
Bork, P .
NUCLEIC ACIDS RESEARCH, 2000, 28 (01) :231-234
[33]   Vaccinia virus immune evasion [J].
Smith, GL ;
Symons, JA ;
Khanna, A ;
Vanderplasschen, A ;
Alcami, A .
IMMUNOLOGICAL REVIEWS, 1997, 159 :137-154
[34]  
Sodhi A, 2000, CANCER RES, V60, P4873
[35]   One step ahead of the game: Viral immunomodulatory molecules [J].
Spriggs, MK .
ANNUAL REVIEW OF IMMUNOLOGY, 1996, 14 :101-130
[36]   Kinetics of Kaposi's sarcoma-associated herpesvirus gene expression [J].
Sun, R ;
Lin, SF ;
Staskus, K ;
Gradoville, L ;
Grogan, E ;
Haase, A ;
Miller, G .
JOURNAL OF VIROLOGY, 1999, 73 (03) :2232-2242
[37]   Transcriptional analysis of human herpesvirus-8 open reading frames 71, 72, 73, K14, and 74 in a primary effusion lymphoma cell line [J].
Talbot, SJ ;
Weiss, RA ;
Kellam, P ;
Boshoff, C .
VIROLOGY, 1999, 257 (01) :84-94
[38]   CLUSTAL-W - IMPROVING THE SENSITIVITY OF PROGRESSIVE MULTIPLE SEQUENCE ALIGNMENT THROUGH SEQUENCE WEIGHTING, POSITION-SPECIFIC GAP PENALTIES AND WEIGHT MATRIX CHOICE [J].
THOMPSON, JD ;
HIGGINS, DG ;
GIBSON, TJ .
NUCLEIC ACIDS RESEARCH, 1994, 22 (22) :4673-4680
[39]   Viral subversion of the immune system [J].
Tortorella, D ;
Gewurz, BE ;
Furman, MH ;
Schust, DJ ;
Ploegh, HL .
ANNUAL REVIEW OF IMMUNOLOGY, 2000, 18 :861-926
[40]   Analysis of cell-adhesion molecule interactions using surface plasmon resonance [J].
vanderMerwe, PA ;
Barclay, AN .
CURRENT OPINION IN IMMUNOLOGY, 1996, 8 (02) :257-261